Finanzwire Finanzwire
Basculer en Français
9473 Companies
185412 Keywords
117769 Articles
99290 Press releases
Headlines Articles Press releases
  1. Home
  2. Press releases
  3. MEDESIS PHARMA A FINALISÉ L’ÉTUDE CLINIQUE POUR LE TRAITEMENT DE LA MALADIE D’ALZHEIMER AVEC LE NANOLITHIUM
Finanzwire
Basculer en Français
Headlines Articles Press releases
REGULATED PRESS RELEASE

published on 11/20/2024 at 17:45 from MEDESIS PHARMA (EPA:ALMDP)

MEDESIS PHARMA A FINALISÉ L’ÉTUDE CLINIQUE POUR LE TRAITEMENT DE LA MALADIE D’ALZHEIMER AVEC LE NANOLITHIUM

image


imageimage

image

image

See all MEDESIS PHARMA news

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2025 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy